Evidence map›Paper›PMID 36988219›Full record

ArticleJournal of psychopharmacology (Oxford, England)2023

The NK1 antagonist L-733,060 facilitates sequence learning.

Natalia Favila, Kevin Gurney, Paul G Overton

Abstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalia FavilaDepartment of Psychology, The University of Sheffield, Sheffield, UK.ORCID 0000-0001-9060-1499
Kevin GurneyDepartment of Psychology, The University of Sheffield, Sheffield, UK.
Paul G OvertonDepartment of Psychology, The University of Sheffield, Sheffield, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough several brain regions and electrophysiological patterns have been related to sequence learning, less attention has been paid to the role that different neuromodulators play.

aimsHere we sought to investigate the role of substance P (SP) in sequence learning in an operant conditioning preparation, supported by a reinforcement learning model.

methodsTwo experiments were performed to test the effects of an NK1 receptor (at which SP primarily acts) antagonist on learning and performing action sequences. In experiment 1, rats were trained to perform an action sequence until stable performance was achieved, and then, in phase 2, they were switched to perform the reverse sequence. In experiment 2, rats were trained to perform an action sequence, and in phase 2, they continued to do the same sequence. In both experiments in the first 3 days of phase 2, rats were injected with an NK1 receptor antagonist (L-733,060, i.p.) or with vehicle. Additionally, we developed a reinforcement learning model which allowed the in silico replication of our experimental tasks.

resultsWe found that administering an NK1 receptor antagonist weakened the stable retention of a well-learned sequence, allowing the faster acquisition of a new sequence, without impairing the continued performance of a crystallized sequence. Using our reinforcement learning model, we suggest that SP could be acting through the state value learning rate, modulating the effects of the reward prediction error.

conclusionsOur results suggest that SP could be involved in the consolidation of a sequence representation through a modulatory effect on the reward prediction error.

Indexed as

LearningReinforcement, PsychologyAnimalsConditioning, OperantPiperidinesRatsReceptors, Neurokinin-1RewardSubstance P3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidinePiperidinesReceptors, Neurokinin-1Substance PAction sequencesreinforcement learningreward prediction errorstriosomessubstance P

Identifiers

PMID36988219
PMCPMC10291388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.